The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The collaboration with IIT Kanpur will build on this foundation and expand the domain of research and development in healthcare technology
Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
The company is one of the most profitable companies manufacturing speciality chemicals in India
All claims against the company in the litigation have now been dismissed.
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
The cash and debt free consideration value is €370 million.
Subscribe To Our Newsletter & Stay Updated
